Canada markets closed

Pascal Biosciences Inc. (PAS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1000-0.0150 (-13.04%)
At close: 2:23PM EDT
Full screen
Previous Close0.1150
Open0.1050
Bid0.1000 x N/A
Ask0.1150 x N/A
Day's Range0.1000 - 0.1050
52 Week Range0.0800 - 0.4500
Volume23,000
Avg. Volume51,067
Market Cap6.509M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0160
Earnings DateApr. 23, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Pascal Biosciences Announces Management Changes

    VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise.

  • ACCESSWIRE

    Pascal Biosciences Inc. Closes Second Tranche of Non-Brokered Private Placement of $750,000

    NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is pleased to announce the closing of the second tranche of the non-brokered private placement announced on November 2, 2020, January 19, 2021 and January 22, 2021 (the "Private Placement").

  • ACCESSWIRE

    Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit

    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today.